AVENUE THERAPEUTICS, INC. (8)
Browse by Contract Category
Contracts
-
Description of Securities of Avenue Therapeutics, Inc
(Filed With SEC on March 25, 2022)
-
Underwriting Agreement, dated December 12, 2021, between Avenue Therapeutics, Inc. and Aegis Capital Corp., as representative of the several underwriters named therein
(Filed With SEC on December 13, 2021)
-
Underwriting Agreement, dated November 9, 2021, between Avenue Therapeutics, Inc. and AEGIS Capital Corp., as representative of the several underwriters named therein
(Filed With SEC on November 10, 2021)
-
Description of Securities
(Filed With SEC on March 31, 2021)
-
Facility Agreement, dated June 12, 2020, by and between Avenue Therapeutics, Inc., InvaGen Pharmaceuticals Inc., and Fortress Biotech, Inc
(Filed With SEC on August 14, 2020)
-
Description of Securities
(Filed With SEC on March 30, 2020)
-
Registration Rights Agreement, dated February 8, 2019, by and between Avenue Therapeutics, Inc. and InvaGen Pharmaceuticals Inc
(Filed With SEC on February 11, 2019)
-
Form of CVR Agreement
(Filed With SEC on February 11, 2019)
